- Home
- NXJ vs SRDX Comparison
NXJ vs SRDX Comparison
Compare NXJ & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXJ
- SRDX
- Stock Information
- Founded
- NXJ 1999
- SRDX 1979
- Country
- NXJ United States
- SRDX United States
- Employees
- NXJ N/A
- SRDX N/A
- Industry
- NXJ Finance/Investors Services
- SRDX Medical/Dental Instruments
- Sector
- NXJ Finance
- SRDX Health Care
- Exchange
- NXJ Nasdaq
- SRDX Nasdaq
- Market Cap
- NXJ 520.4M
- SRDX 562.6M
- IPO Year
- NXJ N/A
- SRDX 1998
- Fundamental
- Price
- NXJ $12.36
- SRDX $38.43
- Analyst Decision
- NXJ
- SRDX Hold
- Analyst Count
- NXJ 0
- SRDX 4
- Target Price
- NXJ N/A
- SRDX $43.00
- AVG Volume (30 Days)
- NXJ 74.9K
- SRDX 244.7K
- Earning Date
- NXJ 01-01-0001
- SRDX 11-06-2024
- Dividend Yield
- NXJ 3.27%
- SRDX N/A
- EPS Growth
- NXJ N/A
- SRDX N/A
- EPS
- NXJ N/A
- SRDX N/A
- Revenue
- NXJ N/A
- SRDX $126,078,000.00
- Revenue This Year
- NXJ N/A
- SRDX N/A
- Revenue Next Year
- NXJ N/A
- SRDX $11.73
- P/E Ratio
- NXJ N/A
- SRDX N/A
- Revenue Growth
- NXJ N/A
- SRDX N/A
- 52 Week Low
- NXJ $10.06
- SRDX $25.17
- 52 Week High
- NXJ $12.24
- SRDX $42.44
- Technical
- Relative Strength Index (RSI)
- NXJ 34.32
- SRDX 57.47
- Support Level
- NXJ $12.22
- SRDX $37.14
- Resistance Level
- NXJ $12.48
- SRDX $38.85
- Average True Range (ATR)
- NXJ 0.12
- SRDX 0.44
- MACD
- NXJ -0.03
- SRDX 0.10
- Stochastic Oscillator
- NXJ 17.95
- SRDX 84.80
About NXJ Nuveen New Jersey Qualified Municipal Fund
Nuveen New Jersey Quality Municipal Income Fund is a closed-end investment management company. Its objective is to provide current income exempt from regular federal and New Jersey income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
About SRDX Surmodics Inc.
Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.